Patients with higher CD74 expression showed a trend for improved OS and DFS compared to those with CD74 low expression, although the differences were not statistically significant, which may due to the low patient number in each group (Fig. 5 H-I).
← all excerpts
CD74 is a potential biomarker predicting the response to immune checkpoint blockade.
1
—
—